Literature DB >> 25234143

Siglec-mediated regulation of immune cell function in disease.

Matthew S Macauley1, Paul R Crocker2, James C Paulson1.   

Abstract

All mammalian cells display a diverse array of glycan structures that differ from those that are found on microbial pathogens. Siglecs are a family of sialic acid-binding immunoglobulin-like receptors that participate in the discrimination between self and non-self, and that regulate the function of cells in the innate and adaptive immune systems through the recognition of their glycan ligands. In this Review, we describe the recent advances in our understanding of the roles of Siglecs in the regulation of immune cell function in infectious diseases, inflammation, neurodegeneration, autoimmune diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25234143      PMCID: PMC4191907          DOI: 10.1038/nri3737

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  148 in total

Review 1.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

Review 2.  CD22 and Siglec-G in B cell function and tolerance.

Authors:  Jonathan C Poe; Thomas F Tedder
Journal:  Trends Immunol       Date:  2012-06-05       Impact factor: 16.687

3.  Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Authors:  N Zimmermann; M L McBride; Y Yamada; S A Hudson; C Jones; K D Cromie; P R Crocker; M E Rothenberg; B S Bochner
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

4.  SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans.

Authors:  Huan Cao; Ursula Lakner; Bernard de Bono; James A Traherne; John Trowsdale; Alexander D Barrow
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

5.  Structural implications of Siglec-5-mediated sialoglycan recognition.

Authors:  Marina A Zhuravleva; Kathryn Trandem; Peter D Sun
Journal:  J Mol Biol       Date:  2007-10-11       Impact factor: 5.469

6.  ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.

Authors:  Roland B Walter; Brian W Raden; Rong Zeng; Peter Häusermann; Irwin D Bernstein; Jonathan A Cooper
Journal:  J Leukoc Biol       Date:  2007-10-18       Impact factor: 4.962

7.  Distinct endocytic recycling of myelin proteins promotes oligodendroglial membrane remodeling.

Authors:  Christine Winterstein; Jacqueline Trotter; Eva-Maria Krämer-Albers
Journal:  J Cell Sci       Date:  2008-02-26       Impact factor: 5.285

8.  Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways.

Authors:  Esra Nutku-Bilir; Sherry A Hudson; Bruce S Bochner
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-09       Impact factor: 6.914

9.  Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.

Authors:  Munetoshi Ando; Wenjie Tu; Ken-Ichi Nishijima; Shinji Iijima
Journal:  Biochem Biophys Res Commun       Date:  2008-03-04       Impact factor: 3.575

10.  Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni.

Authors:  Mariliis Klaas; Cornelia Oetke; Leanne E Lewis; Lars P Erwig; Astrid P Heikema; Alistair Easton; Hugh J Willison; Paul R Crocker
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

View more
  337 in total

1.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

Review 2.  Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.

Authors:  Robert P Schleimer; Ronald L Schnaar; Bruce S Bochner
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-02

3.  Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Authors:  Flavio Schwarz; Stevan A Springer; Tasha K Altheide; Nissi M Varki; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

4.  CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases : English version.

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 5.  [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

6.  Divergent Siglec-F(eights) of mouse and human eosinophil death.

Authors:  Elizabeth A Jacobsen
Journal:  J Leukoc Biol       Date:  2020-06-18       Impact factor: 4.962

7.  Siglec-G represses DAMP-mediated effects on T cells.

Authors:  Tomomi Toubai; Corinne Rossi; Katherine Oravecz-Wilson; Cynthia Zajac; Chen Liu; Thomas Braun; Hideaki Fujiwara; Julia Wu; Yaping Sun; Stuart Brabbs; Hiroya Tamaki; John Magenau; Pang Zheng; Yang Liu; Pavan Reddy
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  The tumour glyco-code as a novel immune checkpoint for immunotherapy.

Authors:  Ernesto RodrÍguez; Sjoerd T T Schetters; Yvette van Kooyk
Journal:  Nat Rev Immunol       Date:  2018-02-05       Impact factor: 53.106

9.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 10.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.